GlassScriptPhysician profile
Swathi Pullela
NPI 1588985196
$1,659.75
in general payments reported to CMS, 2019-2025
17 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $87.22 · 2022: $236 · 2023: $228 · 2024: $394 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.71 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $381.64 | 2019-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $242.94 | 2023-2024 | |
| Novo Nordisk INC | $212.47 | 2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.36 | 2019-2024 | Jardiance |
| Baxter Healthcare | $124.41 | 2024 | |
| Alexion Pharmaceuticals, INC. | $119.31 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $104.80 | 2019-2025 | Voyxact, Jynarque |
| Janssen Biotech, INC. | $59.78 | 2019 | |
| Opko Pharmaceuticals, LLC | $57.61 | 2019 | |
| Vifor Pharma, INC. | $52.69 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $40.66 | 2019 | |
| Bard Peripheral Vascular, INC. | $27.87 | 2019 | |
| Amgen INC. | $18.02 | 2019 | |
| Glaxosmithkline, LLC. | $17.75 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.82 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $13.35 | 2019 | |
| Lundbeck LLC | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swathi Pullela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.